These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8769404)

  • 1. Gs protein mutations and the pathogenesis and function of pituitary tumors.
    Harris PE
    Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
    Faglia G; Arosio M; Spada A
    Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
    Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
    Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
    Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
    Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein abnormalities in pituitary adenomas.
    Spada A; Lania A; Ballarè E
    Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
    Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
    Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
    Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
    J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
    Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
    Adams EF; Lei T; Buchfelder M; Bowers CY; Fahlbusch R
    Mol Endocrinol; 1996 Apr; 10(4):432-8. PubMed ID: 8721987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
    Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y; Tang D; Deng J; Su C
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
    Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL
    J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
    Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
    Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
    Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
    Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
    Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-proteins and hormonal signalling in human pituitary tumors: genetic mutations and functional alterations.
    Spada A; Vallar L; Faglia G
    Front Neuroendocrinol; 1993 Jul; 14(3):214-32. PubMed ID: 8102338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.